New Day Diagnostics, LLC
Country not established
- Devices
- 1
What New Day Diagnostics, LLC makes
New Day Diagnostics, LLC manufactures the Epi proColon, a diagnostic device designed for colorectal cancer screening. This device uses epithelial cell sampling to detect abnormal tissue in the colon, aiding in early detection of precancerous polyps and cancer.
The Epi proColon is classified as a Class III medical device under FDA regulations and is listed under the Premarket Approval (PMA) pathway. The company is based in the United States.
Catalogue
Epi proColon Ref P130001
PMA PMA
Frequently asked questions
How many devices does New Day Diagnostics, LLC have in the registry?
The registry currently lists 1 device for New Day Diagnostics, LLC. Devices recorded under merged duplicate company entries are counted once.
Which registries list New Day Diagnostics, LLC's devices?
Among its 1 most recently registered device, New Day Diagnostics, LLC has devices listed in FDA PMA (1 device).
What risk classes do New Day Diagnostics, LLC's devices fall under?
Among its 1 most recently registered device, the classes recorded for New Day Diagnostics, LLC's devices are Class III. Each device page shows its own class and authorisation.
What are the newest devices from New Day Diagnostics, LLC in the registry?
The most recently registered devices listed for New Day Diagnostics, LLC include Epi proColon.